Skip to content

FX Effect on Cash at other companies

Merck & Co. logo
Merck & Co.MRK
-$19M-112%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$0+100%
Glaukos logo
GlaukosGKOS
-$311K+83.2%
Annexon logo
AnnexonANNX
$1K

Other financials

Income statement

See full
Revenue$3.6B+19.0%
Operating income$642.9M+8.7%
Net income$727.2M-10.1%
EPS (diluted)$6.75-7.2%

Balance sheet

See full
Cash & equivalents$3.0B-4.0%
Total debt$2.7B+0.1%
Total equity$31.4B+6.9%
Total assets$40.9B+8.9%

Cash flow

See full
Operating cash flow$1.1B+3.2%
CapEx$230.6M+0.6%
Free cash flow$848.3M+4.0%

Valuation

See full
Market cap$65.37B+21.9%
Enterprise value$65.11B+20.0%
P/E14.8×+2.8×
P/S4.4×+0.6×

Profitability

See full
Gross margin93.9%
Operating margin24.3%-2.9pp
Net margin29.6%-2.3pp
FCF margin27.6%+5.5pp

Returns & leverage

See full
Return on equity14.5%-1.4pp
Debt / equity0.1×0.0×
Current ratio3.6×-1.4×

Where this comes from

Reported directly by Regeneron Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regeneron Pharmaceuticals's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regeneron Pharmaceuticals's FX effect on cash?
Regeneron Pharmaceuticals (REGN) reported FX effect on cash of -$900K in Q1 2026.
How has Regeneron Pharmaceuticals's FX effect on cash changed year-over-year?
Regeneron Pharmaceuticals's FX effect on cash decreased by 250.0% year-over-year, from $600K to -$900K.
What does FX effect on cash mean?
The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.